-
Symbol
-
TRVI on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
8,508,021 shares
-
Security Ownership %
-
7%
Frazier Life Sciences Public Fund, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
14 Nov 2025 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,508,021 shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
This represents 7% ownership of the company.
In their previous filing dated 15 May 2025, Frazier Life Sciences Public Fund, L.P. had reported owning 10,259,409 shares, indicating a decrease of +17%.
.